BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8219625)

  • 1. [What is the etiology of diabetic retinopathy?].
    Wiedemann P
    Ophthalmologe; 1993 Oct; 90(5):426-33. PubMed ID: 8219625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of growth factors in proliferative diabetic retinopathy.
    Forrester JV; Shafiee A; Schröder S; Knott R; McIntosh L
    Eye (Lond); 1993; 7 ( Pt 2)():276-87. PubMed ID: 7607347
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the pathogenesis of diabetic retinopathy. A 1990 update.
    Frank RN
    Ophthalmology; 1991 May; 98(5):586-93. PubMed ID: 1905795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the pathogenesis of diabetic retinopathy.
    Frank RN
    Ophthalmology; 1984 Jun; 91(6):626-34. PubMed ID: 6205341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericytes and the pathogenesis of diabetic retinopathy.
    Hammes HP
    Horm Metab Res; 2005 Apr; 37 Suppl 1():39-43. PubMed ID: 15918109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factors in proliferative diabetic retinopathy.
    Khan ZA; Chakrabarti S
    Exp Diabesity Res; 2003; 4(4):287-301. PubMed ID: 14668050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outlook for the future in the treatment of diabetic retinopathy].
    Vialettes B; Silvestre-Aillaud P; Atlan-Gepner C
    Diabete Metab; 1994; 20(2 Pt 2):229-34. PubMed ID: 7528151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilation and the etiology of diabetic retinopathy: a new model.
    Wolbarsht ML; Landers MB; Stefansson E
    Ophthalmic Surg; 1981 Feb; 12(2):104-7. PubMed ID: 6164030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of diabetic retinopathy: old concepts and new questions.
    Cai J; Boulton M
    Eye (Lond); 2002 May; 16(3):242-60. PubMed ID: 12032713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological approach to diabetic retinopathy.
    De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
    Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current views on the development of diabetic retinopathy].
    Sosna T
    Cas Lek Cesk; 2002 Nov; 141(22):697-701. PubMed ID: 12532906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of retinal hemodynamics in the pathogenesis of proliferative diabetic retinopathy].
    Glukhoded SV; Pivovarov NN; Simonova KK
    Vestn Oftalmol; 1981; (4):71-3. PubMed ID: 7025434
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
    Gendron RL; Good WV; Adams LC; Paradis H
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factors and diabetic retinopathy.
    Paques M; Massin P; Gaudric A
    Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy: a review.
    Blom ML; Green WR; Schachat AP
    Del Med J; 1994 Jul; 66(7):379-88. PubMed ID: 8062974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the osmotic pressure of the blood in the pathogenesis of diabetic changes in the retina].
    Zapuskalov IV; Filippova SV; Shilova OG; Krivosheina OI
    Vestn Oftalmol; 2000; 116(2):32-4. PubMed ID: 11055223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional diagnostics of retinal ischemia: Muller cells and neovascularization of the retina in diabetic retinopathy].
    Neroev VV; Zueva MV; Tsapenko IV; Riabina MV; Hun L
    Vestn Oftalmol; 2005; 121(1):22-4. PubMed ID: 15759843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.